A next-generation sequencing (NGS) panel for cytology and needle core biopsy samples was able to meet the clinical molecular oncology need, compared to that of surgical resection samples. These data were first presented by Yi Ding, MD, PhD, Cornell University, Ithaca, New York, at the 2025 College of American Pathologists Meeting (CAP25) in Orlando, Florida.
For the full article click here: Success Rate of NGS Panel in Cytology and Needle Core Biopsy Samples